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Wee1 kinase regulates the G2/M cell cycle checkpoint by phosphorylating and inactivating the mitotic 
cyclin-dependent kinase 1 (Cdk1). Loss of Wee1 in many systems, including yeast and drosophila, leads to 
premature mitotic entry. However, the developmental role of Wee1 in mammals remains unclear. In this study, 
we established Wee1 knockout mice by gene targeting. We found that Wee-/- embryos were defective in the G2/M 
cell cycle checkpoint induced by γ-irradiation and died of apoptosis before embryonic (E) day 3.5. To study the 
function of Wee1 further, we have developed MEF cells in which Wee1 is disrupted by a tamoxifen inducible 
Cre-LoxP approach. We found that acute deletion of Wee1 resulted in profound growth defects and cell death. 
Wee1 deficient cells displayed chromosome aneuploidy and DNA damage as revealed by γ-H2AX foci formation 
and Chk2 activation. Further studies revealed a conserved mechanism of Wee1 in regulating mitotic entry and 
the G2/M checkpoint compared with other lower organisms. These data provide in vivo evidence that 
mammalian Wee1 plays a critical role in maintaining genome integrity and is essential for embryonic survival at 
the pre-implantation stage of mouse development. 
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1.  Results and Discussion 
Cells treated with DNA damaging agents, such as 
γ-radiation, coordinately arrest their cell cycle 
progression at varying phases to allow time for 
repairing the DNA damage. This is achieved by the 
activation of cell cycle checkpoints, which monitor 
DNA status and ensure the completion of the previous 
phase in the cell cycle before advancing to the next 
phase [4-7]. It was shown that Wee1 and Cdc25 
cooperatively regulate G2/M boundary by inhibiting 
Cdk1 activity [1, 8, 9]. Wee1 and Cdk1 also regulate 
each other and play a critical role in controlling the 
transition into mitosis [10]. However, the function of 
Wee1 in mammalian development is unknown. To 
investigate this, we have established a Wee1-deficient 
mouse strain by gene targeting and studied its role in 
early mouse embryos and cultured mouse embryonic 
fibroblast (MEF) cells.  
Wee1 was mutated by a replacement type 
gene-targeting vector, ploxPneo-Wee1, which 
introduced a ploxPneo [11] into intron 10 and the third 
loxP into intron 8 of the Wee1 locus, respectively (Fig. 
1A). The correct targeting of the vector followed by 
Cre-loxP mediated recombination would delete exons 
9 and 10, which encode the kinase domain of Wee1. 
Three out of 114 G418r/FIAUr ES clones had both the 
ploxPneo and the loxP introduced into the Wee1 locus 
based on Southern blot analysis (Fig. 1C). After 
germline transmission, we crossed heterozygous 
mutant (Wee1+/neo) mice with EIIa-Cre transgenic mice 
to delete exons 9 and 10 from mouse germline (Fig. 1B). 
Our PCR analysis on genomic DNA extracted from 
mice with various genotypes confirmed the predicted 
targeting and deletion in the Wee1 locus (Fig. 1D). 
Adult  Wee1+/- mice showed no obvious 
abnormality and were fertile. After interbreeding the 
Wee1+/- mice, we failed to obtain Wee1-/- mice from 94 
mice genotyped at weaning while the wild type and 
Wee1+/- mice were presented at a ratio of 1:2.3 (Table 1). 
As no dead Wee1-/- mice were found after birth, we 
suspected that Wee1-/- mice died at embryonic 
development stages. Our analysis of embryos at 
embryonic (E) 13.5 to E7.5 also did not detect any 
homozygotes and abnormal deciduas (Table 1), 
suggesting that the Wee1-/- embryos died at stages prior 
to implantation. To verify this, we isolated E3.5 
embryos derived from Wee1+/- interbreeding. We found 
4 Wee1-/- embryos out of 27 embryos analyzed although 
genotypes of 6 embryos could not be reliably 
determined due to a technical difficulty in 
manipulating small embryos. The majority of the 
Wee1+/+ and Wee1+/- embryos were at the blastocyst 
stage, and possessed a distinct inner cell mass (ICM) 
and an outer layer of trophectoderm cells. The Wee1-/- 
embryos were comprised of fewer cells than their 
Wee1+/+ and Wee1+/- littermates and remained at the 
morulae stage (Fig. 2A-C). The mutant cells were 
disorganized without an obvious compaction. Those 
observations suggest that the development of Wee1-/- 
embryos was interrupted before reaching the 
blastocyst stage. Int. J. Biol. Sci. 2006, 2 
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Because  Wee1-/- embryos were retarded with 
abnormal morphology at the blastocyst stage, we 
investigated whether these embryos would grow if 
extra time was given. To monitor this process, we 
inoculated blastocytsts isolated from Wee1+/- female 
mice, which were mated with Wee1+/- males, into 
24-well culture dishes. Our analysis of 23 blastocysts 
indicated that all embryos showing obvious cell 
proliferation were either Wee1+/+ or Wee1+/- (Fig. 2D,E). 
The remaining 7 embryos, which were abnormal 
initially, did not show any signs of growth and all cells 
degraded during culture (Fig. 2E). Genotype of these 
embryos could not be determined as we failed to 
extract DNA from them. We suspected that most of 
these embryos would be homozygous for Wee1 
mutation based on our earlier observations that Wee1-/- 
embryos were presented at E3.5 with abnormal 
morphology (Fig. 2B,C). Thus, Wee1-/- embryos failed 
to grow even when more time is given. 
Next, we determined potential causes for the 
death of Wee1-/- embryos by TUNEL assay.  Our 
analysis revealed that about 50% of cells in Wee1-/- 
embryos underwent apoptosis while about 5-10% cells 
in wild type and Wee1+/- embryos were TUNEL 
positive (Fig. 3A). There was no statistic difference 
between wild type and Wee1+/- embryos, however the 
differences between wild type and Wee1-/- embryos 
(p<0.001), and between Wee1+/- and Wee1-/- embryos 
(p<0.001) were significant (Fig. 3B). This observation 
suggests that Wee1-/- embryos die at 16-32 cell stages 
due to apoptosis. 
Next, we studied possible causes for the 
increased apoptosis observed in Wee1-/- embryos.  In 
vitro studies revealed that Wee1 plays an essential role 
in the G2/M cell cycle checkpoint [1, 8, 9]. Therefore, 
we investigated whether Wee1 had a similar role in 
vivo. We isolated embryos at E2.5 and E3.5 from 
Wee1+/- females after they were mated with Wee1+/- 
male mice. The mitotic index was determined in these 
embryos prior to, and after they were irradiated with 
γ-radiation (10 Gy) using an antibody against 
phosphorylated histone H3. A significant decrease in 
the number of mitotic cells was observed in both E2.5 
Wee1+/+ and Wee1+/- embryos after irradiation while no 
obvious change was seen in Wee1-/- embryos (Fig. 3C-E). 
This observation suggests that Wee1-/- embryos were 
defective in activating the G2/M cell cycle checkpoint 
induced by DNA damage. The mitotic index of E3.5 
embryos declined from 20% to 4% (p=0.048), from 27% 
to 13% (p=0.056) in Wee1+/- embryos, and from 65% to 
60% (p=0.594) in Wee1-/-  embryos (Fig. 3C). Thus, 
compared with Wee1+/+ embryos, absence of one wild 
type copy of Wee1 in E3.5 embryos might result in a 
partial loss of the G2/M checkpoint induced by 
γ-irradiation. Of note, Wee1-/- embryos had much more 
mitotic cells than Wee1+/+ and Wee1+/- embryos at both 
time points prior to irradiation. Thus, although the 
Wee1-/- embryos appeared morphologically normal at 
E2.5, some fundamental alterations at cellular level 
had already started, which might account for the 
developmental abnormality shown in the blastocyst 
stage.  
To study cellular defects associated with Wee1 
deficiency, we established MEF cells allowing for the 
acute mutation of Wee1 using a 4-hydroxytamaxifen 
(4-HT) inducible Cre-LoxP system. These cells 
(Wee1Co/-;Tm-Cre) carried a conditional Wee1 allele with 
its exons 9 and 10 flanked by loxP sites (Fig. 4A), a 
mutant allele missing exons 9 and 10, and a tamoxifen 
inducible Cre gene (Tm-Cre) [12]. Treatment with 4-HT 
in these cells causes nuclear translocalization of Cre, 
leading to the deletion of the conditional allele (Fig. 4B). 
Our MTT assay revealed significantly reduced cell 
quantity after the Wee1Co/-;Tm-Cre cells were exposed to 
4-HT compared with untreated or vehicle (ethanol) 
treated cells (Fig. 5A). In contrast, only slight reduction 
in cell quantity was observed in control cells 
(Wee1+/Co;Tm-Cre, Wee1+/+;Tm-Cre, and Wee1+/-;Tm-Cre) 
after they were treated with 4-HT compared to 
untreated or vehicle treated cells (data not shown). 
Microscopic analysis revealed that many of the 4-HT 
treated  Wee1Co/-;Tm-Cre cells showed nuclear 
fragmentation and membrane blebbing, and were 
rounded up detaching from the culture plate (Fig. 6A). 
These abnormalities were not seen in untreated cells 
(Fig. 6B). Staining with annexin-V, we detected 
increased apoptotic cells 24 hours upon the addition of 
4-HT (Fig. 5B), while the fraction of BrdU positive cells 
maintained unaltered (not shown).  
Because our analysis of E2.5-3.5 embryos 
indicated that the absence of Wee1 impaired the G2/M 
cell cycle checkpoint, we next studied this cell cycle 
checkpoint in the cultured MEF cells. Our analysis 
revealed a sharp reduction of the mitotic index in the 
ethanol treated Wee1Co/-;Tm-Cre cells one hour after 
γ-irradiation, while only a slight reduction of mitotic 
fraction was observed in the in 4-HT treated cells (Fig. 
5C), suggesting a defective G2/M checkpoint in these 
cells. Based on this observation, we conclude that 
Wee1 plays a critical role in G2/M cell cycle 
checkpoint in mouse cells both in vitro and in vivo.  
Of note, the growth defects observed in Wee1 
deficient cells are much more severe than those 
observed in many other mutant cells that are defective 
in the G2/M cell cycle checkpoint, such as BRCA1 [13] 
or ATM mutant [14] cells, suggesting the phenotypes 
associated with Wee1 deficiency could also be 
contributed to other defects in addition to the defective 
G2/M cell cycle checkpoint. It was shown previously 
in budding yeast and Drosophila that the absence of 
Wee1 results in premature entry of mitosis [2, 3]. To 
investigate whether Wee1 deficiency impairs this 
function in the mouse, we analyzed the Wee1Co/-;Tm-Cre 
cells for a possible defect in this checkpoint in the 
absence or presence of 4-HT. Using double 
immunofluorescent staining with antibodies against 
BrdU and phosphorylated histone H3, we found about 
40% of histone H3 positive Wee1Co/-;Tm-Cre cells were 
also positive for BrdU when analyzed 24 hours after 
4-HT exposure, while only less than 5% of ethanol 
treated cells were double positive (Fig. 5D-F). To Int. J. Biol. Sci. 2006, 2 
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provide independent confirmation, we had also 
stained Wee1Co/-;Tm-Cre cells with PI and an antibody 
against phosphorylated histone H3 followed by flow 
cytometry analysis. We found that about 50% of 
phosphorylated H3 positive cells had a DNA content 
less than 4n while this was not found in the untreated 
population (Fig. 5G). Thus, like the yeast and 
Drosophila, the absence of Weel triggered premature 
entry into mitosis. 
Because Wee1 is a negative regulator of Cdk1, the 
absence of Wee1 is predicted to increase Ckd1 activity. 
To investigate if the premature mitotic entry observed 
in the Wee1 mutant cells is indeed associated with the 
increased Cdk1 activity, we first examined the level of 
Cdk1-Tyr15, which is specifically phosphorylated by 
Wee1 [1, 8, 9]. Our data revealed a significant 
reduction of Cdk1 phosphorylation at Tyr15 24 hours 
after 4-HT treatment (Fig. 5H), indicating that Cdk1 is 
activated in the absence of Wee1. To test whether the 
activation of Cdk1 is responsible for premature mitotic 
entry, we treated Wee1Co/-;Tm-Cre cells with 4-ht in the 
presence or absence of purralanol A that specifically 
inhibits Cdk1 activity. Our data indicated that while 
purralanol A reduced slightly the percentage of BrdU 
positive cells (Fig. 5I), it decreased significantly the 
fraction of mitotic cells (Fig. 5J), leading to the blocking 
of premature mitotic entry of 4-HT treated 
Wee1Co/-;Tm-Cre cells (Fig. 5K) 
Western blot analysis also revealed increased 
phosphorylation of Chk2 upon acute deletion of Wee1 
(Fig. 5H). Because Chk2 is phosphorylated by ATM 
upon DNA damage [15], we checked DNA damage in 
the 4-HT treated Wee1Co/-;Tm-Cre cells using an 
antibody against phosphorylated form of H2AX 
(γ-H2AX), which relocates to double strand breaks 
(DSBs) upon DNA damage [16]. This analysis detected 
a robust increase of γ-H2AX nuclear foci in the 
Wee1Co/-;Tm-Cre cells 24 hours after 4-HT treatment but 
not in the ethanol treated cells (Fig. 7A,B). Correlating 
with DNA damage, the 4-HT treated Wee1Co/-;Tm-Cre 
cells 24 hours exhibited increased chromosome 
aneuploidy compared with ethanol treated cells (Fig. 
7C-E). Because Wee1 does not play a direct role in 
DNA damage repair, we believe that the premature 
mitotic entry due to Wee1 deficiency could be a cause 
for DSBs when mutant cells try to initiate mitosis prior 
to the completion of semi-conservative DNA 
replication. The DSBs and genetic instability in Wee1 
deficient cells, in turn, trigger the DNA damage 
response, leading to the increased cell death. 
In conclusion, our analysis on Wee1-null embryos 
and Weel-conditional mutant MEFs indicates that 
Wee1 plays an essential role in maintaining genetic 
stability and embryonic survival at the 
pre-implantation stage of mouse development. Our 
data revealed that similar to lower organisms [2, 3], 
murine Wee1 controls mitotic entry and the G2/M cell 
cycle checkpoint through the regulation of Cdk1 
activity. Recent studies reveal that Wee1 serves as a 
downstream mediator of the breast cancer associated 
gene 1 (BRCA1) in activating the G2/M cell cycle 
checkpoint upon DNA damage [17, 18]. Future studies 
should be directed to the relationship between BRCA1 
and Wee1 in breast cancer formation and genomic 
integrity. In addition, phenotypes associated with 
Wee1-deficiency, in terms of embryonic lethality, 
premature mitotic entry and defective G2/M cell cycle 
checkpoint, are similar to those caused by Chk1-null 
mutation [19, 20]. Because activity of Chk1 is also 
found to be regulated by BRCA1 [17, 18], the genetic 
interplay between Chk1 and Wee1 should also be 
addressed in future studies. A recent investigation 
indicates that cell division in many mammalian tissues 
may be associated with specific times of day and that 
regulation of Wee1 expression by the molecular 
components of the circadian clockwork may play a key 
role in this process [21]. Conditional mutations of 
Wee1 using a Cre-loxP approach [22-24] to overcome 
early embryonic lethality would facilitate functional 
study of Wee1 in all phases of murine development. 
2.  Experimental Procedures 
Establishment of Wee1 Knockout Mice 
To make a targeting vector for Wee1, we isolated 
mouse  Wee1 genomic DNA from a mouse 129SVEV 
genomic library using a 904 bp Wee1 cDNA fragment 
(from 895 to 1799bp) as a probe. A 5.4 kb fragment, 
which is 5’ to the exon 11 starting from a XhoI site in 
intron 10 of Wee1 gene, was inserted into the pLoxPneo 
plasmid [25] that was digested with NotI and XhoI. 
The resulting construct was digested with SalI 
followed by insertion of a 3 kb fragment, which starts 
from the XhoI site in the intron 10 to a SalI site 3’ to 
exon 11. A loxP sequence [11] was inserted into a BbeI 
site in 5’ arm (Fig. 1A). After electroporation of the 
targeting vector into mouse TC-1 ES cells [26], we 
analyzed G418 and FIAU double resistant clones for 
homologous recombination in the Wee1 locus. 
Genomic DNAs from these clones were digested with 
EcoRV followed by Southern transfer analysis using a 
5’ flanking probe and then a 3’ internal probes. The 5’ 
flanking probe is a 338 bp fragment obtained by PCR 
using the following primers: 5’ GAT ATCAAG CCA 
GGG CTT TG 3’ and 5’ GAG AAA GGC TAT ACA 
ACT TTG AAG 3’. The 3’ internal probe is a 1,908 bp 
fragment obtained by PCR using the following primers: 
5’ GGC TTC TTA GAC TCT TTC CA 3’ and 5’ GTT 
GGG TTG GAT GTT TAG AG 3’.  Two ES clones 
containing correct target event were injected into 
blastocysts derived from C57B6 mice to generate 
chimeric mice, and germline transmissions following a 
mating procedure as previously described [11].  
To establish the mice carrying Wee1 mutant allele, 
we mated F1 mutant mouse (Wee1+/neo) with the 
EIIa-Cre t r a n s g e n i c  f e m a l e  m i c e  [ 2 7 ] .  G e n o m i c  D N A  
was extracted from the tail of offspring followed by 
PCR genotyping. Heterozygous mice containing 
predicted deletion of both exons 9 and 10 were named 
as  Wee1+/- and were further interbred to generate 
Wee1-/- mice.  Int. J. Biol. Sci. 2006, 2 
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PCR Genotyping for Blastocysts 
Blastocysts were transferred into eppendorf tubes 
containing 20 μl of 5X PCR buffer. They were 
incubated at 60°C for overnight followed by 100°C for 
10 min. We performed PCR amplification using these 
samples with these primers (35 cycles of 94°C for 30 
sec., 60°C for 30 sec. and 72°C for 2 min. 30 sec. and 
following 72°C for 10 min.). We used the following pair 
of primers (5’ TGT CTA CAA GTT GTC TTG TCA 
TGA 3’ and 5’ ACT GTG GAG AGC TCT CAA TG 3’) 
to amply Wee1 wild type allele (369 bp) and another set 
of primer (5’ TGT CTA CAA GTT GTC TTG TCA TGA 
3’ and 5’ CTG CAG GCA AAC CTG TTT C 3’) for Wee1 
mutant allele (253 bp). PCR products were analyzed 
running into 2% agarose gel.    
TUNEL Assay for Blastocysts 
Blastocysts were washed with 1% BSA in PBS 2 
times at 4°C, and fixed with 4% paraformaldehyde in 
PBS at room temperature for 30 min. They were then 
incubated with 0.1% sodium citrate, 0.1% Triton-X 100, 
1% BSA in PBS for 2 min at 4°C, washed with 1% BSA 
in PBS 2 times at 4°C, and incubated in TUNEL 
reaction mixture (Roche) at 37°C for 60 min in dark. 
After washing with 1% BSA in PBS 2 times at 4°C and 
incubated with DAPI in PBS, they were observed with 
an inverted fluorescent microscope (Model IX81F, 
Olympus) and photographed by a cooled CCD color 
camera, CoolSNAP FX (Photometrics) and IPLab 
Scientific Image Processing 3.6.3 (Scanalytics, Inc) as 
the software. 
Analysis of G2/M Cell Checkpoint in Blastocysts 
Blastocysts in Brinster’s BMOC-3 medium (Gibco) 
were treated with γ-ray (10 Gy) and incubated for three 
hours at 37°C in CO2 incubator. After incubating them 
with growth medium containing nocodazole (0.1 
ng/ml) for another 3 hours, they were fixed with 4% 
paraformaldehyde in PBS at room temperature for 30 
min followed by the treatment of 0.15% triton-X and 
1.5% BSA in PBS for 20 min at room temperature.  The 
embryos were then incubated with a polyclonal 
antibody to phosphorylated histone H3 at Ser10 (1:300 
dilution, Upstate biotechnology) in 1.5% BSA in PBS 
for 20 min at room temperature and followed by a 2nd 
antibody (1:200 dilution, Alexa Fluor 488 gout 
anti-rabbit IgG (H+L) Molecular probes) with DAPI 
(100 ng/ml) for 1 hour at room temperature before 
imaging analysis. 
MEF Cells and Treatment 
MEF cells were derived from E14.5 embryos 
generated from intercrosses of Wee1+/Co;Tm-Cre mice. 
For MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide] assay, we plated 2X104 cells into 
each well of a 24-well plate and 4-HT at 1mM was 
added twenty-four hours later. At different time points 
after further incubation, we removed the medium, 
added 0.5 ml of 0.1% MTT solution dissolved by PBS in 
each well. 30 min after in 37°C CO2 incubator, we 
removed the MTT solution and added 0.4 ml of 
2-propanol. After 30 min shaking, we measured 
OD560 by a plate reader. Analysis for the irradiation 
induced G2/M cell cycle checkpoint and 
annexin-V-FITC positive Cells were performed as 
described by [13] and [28], respectively. For analysis of 
premature mitotic entry, cells grown on glass slides 
were paused labeled with BrdU half hours before they 
were fixed with 70% ethanol for 30 min. The cells were 
washed with PBS, suspended in 1 ml of 2N HCl, 0.5% 
Triton X-100 and incubated for 30  min, and in 0.5% 
Triton X-100 in PBS incubated for 10 min. The cells 
were stained with antibodies to BrdU 
(Becton-Dickinson) phosphorylated histone H3 
(Upstate biotechnology) followed by secondary 
antibody.  
Immunoblot Analysis 
Western blot analysis was accomplished 
according to standard procedures using ECL detection 
(Amersham). The following primary antibodies were 
used: Chk2 (Transduction Laboratories), Wee1 (H-3 
Santa Cruz), Cdk1, (SC-54 Santa Cruz), and 
Phospho-Cdk1 (Tyr-15) (#9111, Cell Signaling), and 
β-actin (Sigma).  Horseradish peroxidase-conjugated 
anti-rabbit, sheep, and anti-mouse antibodies 
(Amersham) were used as secondary antibodies.  
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Table 1. Genotypes of offspring of Wee1
+/- interbreeding 
 
Figure 1.  Generation of Wee1 knockout mice. (A) Structure 
of Wee1 targeting vector, ploxPneoWee1 (upper) and map of 
a part of normal mouse Wee1 gene (lower). Be: BbeI, Ev: 
EcoRV, S: SalI, and Xh: XhoI. Probes used were as indicated. 
Probes “a”, which is 5’ flanking the targeting vector, and 
probe “b”, which is located in the 3’ arm of the targeting 
vector, were used in Southern blot analysis. (B) Structure of 
targeted allele (upper), and exons 9/10 deleted allele (lower). 
(C) Southern blot showed targeted allele (lanes 2 and 3) after 
EcoRV digestion and probed with probe b. (F) PCR based 
genotype of offspring obtained from crosses between 
Wee1
+/neo and EIIa-Cre mice. Primer 1: 5’ TGT CTA CAA 
GTT GTC TTG TCA TGA 3’, Primer 2: 5’ ACT GTG GAG 
AGC TCT CAA TG 3’, Primer 3: 5’ CTC CAG GTG TGT 
CAT ATA CC 3’, Primer 4: 5’ CCG TTC CTC AGC TGC 
AAC TT 3’. 
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Figure 2. Abnormal appearance of Wee1
-/- embryos at pre-implantation stages. (A,B) Images of Wee1
+/+ (A) and Wee1
-/- (B) 
embryos. (C) Genotyping of E3.5 embryos by PCR. (D,E) Morphology (D) of blastocysts after they were cultured after 
different times as indicated. All embryos showing proliferation were either Wee1
+/+ or Wee1
+/- embryos. Genotypes (E) were 
determined by PCR 4 days after culture.  
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Figure 3. Apoptosis and impaired G2/M cell cycle checkpoint in Wee1
-/- embryos. (A, B) TUNEL assay revealed increased 
apoptosis in Wee1
-/- embryos. (C,D)  Mitotic cells in E2.5 embryos. (E,F) Mitotic index of E2.5 and E3.5 embryos. Each graph 
bar summarizes data obtained from at least 4 embryos. 
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Figure 4.  Generation of tamoxifen inducible Wee1 knockout MEF cells. (A) Structure of conditional allele (upper) and exons 
9/10 deleted allele (lower). (B) PCR based genotyping of Wee1
Co/+ and Wee1
Co/-;Tm-Cre MEFs in the presence (+) or absence 
(-) of 4-ht.  The same primers were used for genotyping as shown in Fig. 1. 
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Figure 5. Increased cell death and impaired cell cycle regulation of Wee1-deficient cells (A) MTT assay of Wee1
Co/-;TM-cre 
MEF cells that were treated with ethanol or no treatment (upper curve), or 1μM of 4-HT. (B) Apoptotic fraction of 
Wee1
Co/-;TM-cre MEF cells after 4-ht treatment revealed by annexin V and EtBr staining. (C) Defective G2/M cell cycle 
checkpoint of Wee1
Co/-;TM-cre MEF cells. Cells were treated with 1 μM 4-HT for 24 hours and fixed at 1-4 hours after they 
were irradiated with 10 Gy γ-ray. (D,E) Premature entry into mitosis revealed by BrdU and histone H3 double staining. 
Wee1
Co/-;TM-cre MEFs were incubated in the absence (D) or presence (E) of 4-HT for 24 hours prior to the staining. (F) 
Percentage of BrdU and histone H3 double positive cell. The percentage is calculated by the following formula 
[(BrdU
++H3Pi
+)/H3Pi
+].  (G) Flow cytometry analysis of mitotic cells in ethanol or 4-ht treated Wee1
Co/-;TM-cre MEFs by PI 
and H3Pi staining.  (H) Western blotting of Wee1
Co/-;TM-cre MEFs. The arrow points to the phosphorylated form of Chk2 
after lighter expossure of the gel. (I,J,K) Effect of purralanol A (10 μM) on mitotic entry of Wee1
Co/-;Tm-Cre cells in the 
absence (-) and presence (+) of 4-HT. Percentages of BrdU (I), H3Pi (J), and double (K) positive cells were shown.  
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Figure 6. Morphology of Wee1
Co/-;Tm-Cre MEFs in the presence (A) and absence (B) of 4-HT for 48 hours. 
 
Figure 7.    DNA damage and chromosome instability of Wee1
Co/-;TM-cre MEF cells. (A,B) Immunofluorescent staining of 
Wee1
Co/-;TM-cre MEF cells using an antibody to γ-H2AX in the absence (A) or presence (B) of 1 μM 4-ht for 24 hours. (C,D) 
Chromosome spread of Wee1
Co/-;TM-cre MEF cells after they were grown in the absence (C) or presence (D) of 1 μM 4-ht for 
24 hours. (E) A summary of chromosomal spreading data from more than 60 cells in the absence (black bar) and presence 
(open bar) of 4-HT.  
 